Recombinant Human Angiotensin-converting enzyme 2 (ACE2), APN01

( DrugBank: Angiotensin, Recombinant Human Angiotensin-Converting Enzyme 2 / KEGG DRUG: Angiotensin II, Angiotensin II )

1 disease

ID	Disease name (Link within this page)	Number of trials
86	Pulmonary arterial hypertension	2

86. Pulmonary arterial hypertension

Clinical trials : 1,205 / Drugs : 684 - (DrugBank : 124) / Drug target genes : 100 - Drug target pathways : 193

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2017-000212-41-DE (EUCTR)	01/09/2017	27/06/2017	Study to test a new drug to treat patients with Pulmonary Arterial Hypertension (PAH)	An Open-label, Dose-escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Phar ...	Pulmonary arterial hypertension MedDRA version: 20.0;Level: PT;Classification code 10064911;Term: Pu ...	Product Name: GSK2586881 Product Code: GSK2586881 INN or Proposed INN: GSK2586881 Other descriptive nam ...	GlaxoSmithKline Research & Development Ltd	NULL	Not Recruiting			Female: yes Male: yes	24	Phase 2	United States;Germany;Spain
2	EUCTR2017-000212-41-ES (EUCTR)	10/08/2017	22/06/2017	Study to test a new drug to treat patients with Pulmonary Arterial Hypertension (PAH).	An Open-label, Dose-escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Phar ...	Pulmonary arterial hypertension MedDRA version: 20.0;Level: PT;Classification code 10064911;Term: Pu ...	Product Name: GSK2586881 Product Code: GSK2586881 INN or Proposed INN: GSK2586881 Other descriptive nam ...	GlaxoSmithKline, S.A.	NULL	Not Recruiting			Female: yes Male: yes	24	Phase 2	United States;Spain;Germany

First Previous1Next Last